Peter D. Simone

421 total citations
10 papers, 232 citations indexed

About

Peter D. Simone is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Peter D. Simone has authored 10 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Physiology. Recurrent topics in Peter D. Simone's work include Biochemical and Molecular Research (4 papers), Adenosine and Purinergic Signaling (3 papers) and Renal cell carcinoma treatment (2 papers). Peter D. Simone is often cited by papers focused on Biochemical and Molecular Research (4 papers), Adenosine and Purinergic Signaling (3 papers) and Renal cell carcinoma treatment (2 papers). Peter D. Simone collaborates with scholars based in United States, Russia and France. Peter D. Simone's co-authors include Youri I. Pavlov, Luis A. Marky, Xiaojian Wang, Elena I. Stepchenkova, Kathryn M. Spitler, Joyce C. Solheim, Elena Tarakhovskaya, Miriam R. Menezes, Carol Kolar and Alyssa E. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Molecular Biology.

In The Last Decade

Peter D. Simone

10 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter D. Simone United States 7 148 37 34 32 32 10 232
Michaela Schneider Germany 7 274 1.9× 53 1.4× 29 0.9× 14 0.4× 23 0.7× 14 379
Chris Clarke Australia 4 112 0.8× 48 1.3× 42 1.2× 32 1.0× 100 3.1× 4 225
R Sorrentino Italy 8 157 1.1× 118 3.2× 77 2.3× 122 3.8× 16 0.5× 20 354
Despoina Koumantou France 8 100 0.7× 121 3.3× 68 2.0× 22 0.7× 122 3.8× 15 263
Christine Kinnon United Kingdom 9 114 0.8× 49 1.3× 13 0.4× 61 1.9× 236 7.4× 15 394
Suhas Darekar Sweden 9 145 1.0× 62 1.7× 50 1.5× 10 0.3× 49 1.5× 16 261
Raghavendar T. Nagaraju United Kingdom 6 99 0.7× 45 1.2× 17 0.5× 86 2.7× 103 3.2× 13 268
Amagoia Ametzazurra Spain 8 195 1.3× 67 1.8× 35 1.0× 58 1.8× 155 4.8× 16 423
Xuefeng Bu China 12 304 2.1× 81 2.2× 62 1.8× 29 0.9× 45 1.4× 23 439
Angela Hughson United States 11 52 0.4× 103 2.8× 34 1.0× 25 0.8× 311 9.7× 15 434

Countries citing papers authored by Peter D. Simone

Since Specialization
Citations

This map shows the geographic impact of Peter D. Simone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Simone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Simone more than expected).

Fields of papers citing papers by Peter D. Simone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Simone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Simone. The network helps show where Peter D. Simone may publish in the future.

Co-authorship network of co-authors of Peter D. Simone

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Simone. A scholar is included among the top collaborators of Peter D. Simone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Simone. Peter D. Simone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Labriola, Matthew, Jason Zhu, Rajan T. Gupta, et al.. (2019). Characterization of tumor mutational burden (TMB), PD-L1, and DNA repair genes to assess correlation with immune checkpoint inhibitors (ICIs) response in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(15_suppl). e16079–e16079. 4 indexed citations
2.
Labriola, Matthew, Jason Zhu, Rajan T. Gupta, et al.. (2019). Characterization of tumor mutational burden (TMB), PD-L1, and DNA repair genes to assess correlation with immune checkpoint inhibitors (ICIs) response in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(7_suppl). 589–589. 6 indexed citations
3.
Mir, Riyaz Ahmad, Nicholas P. Schafer, Peter D. Simone, et al.. (2016). Biophysical characterization and modeling of human Ecdysoneless (ECD) protein supports a scaffolding function. AIMS Biophysics. 3(1). 195–210. 4 indexed citations
4.
Rohr, Joseph, Shuangping Guo, Dongdong Hu, et al.. (2014). CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression. Blood. 124(21). 1681–1681. 7 indexed citations
5.
Simone, Peter D., et al.. (2013). ITPA (inosine triphosphate pyrophosphatase): From surveillance of nucleotide pools to human disease and pharmacogenetics. Mutation Research/Reviews in Mutation Research. 753(2). 131–146. 44 indexed citations
6.
Simone, Peter D., et al.. (2013). Simulation of modulated protein crystal structure and diffraction data in a supercell and in superspace. Acta Crystallographica Section D Biological Crystallography. 69(6). 1062–1072. 8 indexed citations
7.
Simone, Peter D., et al.. (2013). The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core. Journal of Structural Biology. 182(3). 197–208. 14 indexed citations
8.
9.
Johnson, Alyssa E., William A. Callahan, Alexis D. Smith, et al.. (2010). Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.. PubMed. 23(3). 861–7. 71 indexed citations
10.
Stepchenkova, Elena I., Elena Tarakhovskaya, Kathryn M. Spitler, et al.. (2009). Functional Study of the P32T ITPA Variant Associated with Drug Sensitivity in Humans. Journal of Molecular Biology. 392(3). 602–613. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026